Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.81 USD | -0.92% | +1.79% | -24.46% |
Apr. 29 | OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024 | CI |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
Business Summary
Number of employees: 136
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Intelligent Technology Platform
100.0
%
| 62 | 100.0 % | 72 | 100.0 % | +14.53% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 62 | 100.0 % | 72 | 100.0 % | +14.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
President | 46 | 19-04-28 | |
Todd Inman
CTO | Chief Tech/Sci/R&D Officer | 69 | 18-12-31 |
Compliance Officer | 60 | 21-02-07 | |
Andrew D'Silva
IRC | Investor Relations Contact | - | - |
Theresa Greco
PRN | Corporate Officer/Principal | - | 23-10-24 |
Sheryl Kearney
HRO | Human Resources Officer | - | 19-11-30 |
Sales & Marketing | 58 | 08-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | Jan. 23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
Ellen Vos
CHM | Chairman | 68 | 15-09-23 |
Jim Lang
BRD | Director/Board Member | 59 | 17-01-11 |
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,925,311 | 15,877,493 ( 79.69 %) | 1,741,397 ( 8.740 %) | 79.69 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.46% | 197M | |
+26.36% | 441B | |
+25.47% | 263B | |
+8.80% | 140B | |
+7.48% | 92.89B | |
+25.85% | 90.53B | |
+56.78% | 58.64B | |
+16.13% | 46.96B | |
+2.85% | 36.7B | |
+20.84% | 36.11B |
- Stock Market
- Equities
- OPRX Stock
- Company OptimizeRx Corporation